Ayer, T. Et Al. 2024. Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France. HIV Drug Therapy Glasgow , (Glasgow, England), 233-234.

Ayer, T., Gursel, E., Edalı, M., Idelovici-Marchal, C., Benabadji, E., Jarrett, J., ... Mezzio, D.(2024). Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France . HIV Drug Therapy Glasgow (pp.233-234). Glasgow, England

Ayer, Turgay Et Al. "Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France," HIV Drug Therapy Glasgow, Glasgow, England, 2024

Ayer, Turgay Et Al. "Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France." HIV Drug Therapy Glasgow , Glasgow, England, pp.233-234, 2024

Ayer, T. Et Al. (2024) . "Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France." HIV Drug Therapy Glasgow , Glasgow, England, pp.233-234.

@conferencepaper{conferencepaper, author={Turgay Ayer Et Al. }, title={Estimating return on investment (ROI) with increased utilisation of HIV pre‐exposure prophylaxis (PrEP) among key populations in France}, congress name={HIV Drug Therapy Glasgow}, city={Glasgow}, country={England}, year={2024}, pages={233-234} }